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Homeostasis of short-lived blood cells is dependent
on rapid proliferation of immature precursors. Using
a conditional histone 2B-mCherry-labeling mouse
model, we characterize hematopoietic stem cell
(HSC) and progenitor proliferation dynamics in
steady state and following several types of induced
stress. HSC proliferation following HSC transplanta-
tion into lethally irradiated mice is fundamentally
different not only from native hematopoiesis but
also from other stress contexts. Whereas transplan-
tation promoted sustained, long-term proliferation
of HSCs, both cytokine-induced mobilization and
acute depletion of selected blood cell lineages eli-
cited very limited recruitment of HSCs to the prolifer-
ative pool. By coupling mCherry-based analysis of
proliferation history with multiplex gene expression
analyses on single cells, we have found that HSCs
can be stratified into four distinct subtypes. These
subtypes have distinct molecular signatures and
differ significantly in their reconstitution potentials,
showcasing the power of tracking proliferation
history when resolving functional heterogeneity of
HSCs.INTRODUCTION
As most mature blood cells are short-lived, they are in need of
continuous replacement to ensure a sufficient capacity of the he-
matopoietic system. Hematopoiesis is therefore characterized
by vigorous proliferation, although magnitudes differ depending
on the developmental stages at which defined progenitors reside
(Passegue´ et al., 2005). Historically, it has been argued that he-
matopoietic stem cells (HSCs) are critically responsible for theCellmaintenance of homeostasis within the hematopoietic system
(Bryder et al., 2006), a presumption which is largely based on
HSCs residing at the apex of the hematopoietic hierarchy, their
multipotency, and their extensive longevity/self-renewal. Impor-
tantly, however, these features have been predominantly defined
by transplantation experiments.
In clinical hematopoietic stem and progenitor cell (HSPC)
transplantations, patients are commonly conditioned with mye-
loablative chemotherapy and/or irradiation before receiving a
graft, with HSPCs to be used for transplantation typically har-
vested from donors following cytokine-induced mobilization.
Challenges in assessing HSC quality and quantity in humans
preclude assessment of how such therapeutic regimens influ-
ence HSC properties and functional potential both short- and
long-term post-transplantation. This might be particularly rele-
vant for the transplantation setting, in which HSCs are sub-
jected to very high and arguably abnormal proliferation
pressures that adult HSCs under physiological conditions are
not exposed to.
Initial indications that proliferative status might be an impor-
tant determinant for the functional capacity of HSC were ob-
tained from transplantation studies in which bone marrow (BM)
cells in active cell cycle, and enriched for HSC activity, displayed
a diminished ability to rescue lethally irradiated hosts (Fleming
et al., 1993). Later, more refined HSC enrichment strategies
confirmed that adult HSCs are normally residing in the G0/G1
phase of the cell cycle (Cheshier et al., 1999; Morrison and
Weissman, 1994; Morrison et al., 1997), with transplantation ex-
periments revealing a sharp reduction in the reconstitution ca-
pacity of candidate and actively cycling HSCs (Glimm et al.,
2000; Habibian et al., 1998; Nygren et al., 2006; Orschell-Trayc-
off et al., 2000). With this said, fetal liver HSCs, which are known
to actively cycle, are nonetheless much more potent than adult
HSCs in a transplantation setting (Jordan et al., 1995; Rebel
et al., 1996a, 1996b). In addition, convincing demonstrations
that HSCs in active cell cycle can be reverted to a G0 state,
with a robust regain in their reconstitution potential, are still lack-
ing (Nygren et al., 2006). Therefore, when caught in active cellReports 14, 2809–2818, March 29, 2016 ª2016 The Authors 2809
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Figure 1. Description and Functional Valida-
tion of an Inducible H2B-mCherry Labeling
Mouse Model
(A) Schematic representation of the Col1a1-tetO-
H2B-mCherry model. Expression of the M2
reverse tetracycline transactivator (M2-rtTA) is
driven by the Rosa26 promoter with H2B-mCherry
positioned in the 30 UTR of the Col1a1 gene under
control of a tetracycline operon (TetOP). pA, pol-
yadenylation signal; SA, splice acceptor.
(B) Schematic outline depicting the principle of
H2B-mCherry labeling and label dilution using the
Col1a1-tetO-H2B-mCherry system.
(C) H2B-mCherry mRNA expression relative to
b-actin in HSCs and myeloid progenitors following
a 7-day pulse and 7 days chase.
(D) Representative FACS histograms showing
H2B-mCherry label in HSCs from heterozygous
and homozygousCol1a1-tetO-H2B-mCherry mice
fed for 1 week with ‘‘standard’’ (blue line;
200 mg/kg) or high (red filled histograms; 2 g/kg)
DOX food pellets.
(E) H2B-mCherry label in progenitors downstream
of HSCs following 1-week administration of high-
concentration DOX followed by no or 7 days
chase. Grey histograms depict mCherry expres-
sion in HSPCs from non-induced Col1a1-tetO-
H2B-mCherry mice.
(F) Fgd5-ZsGreen expression and H2B-mCherry
label retention in HSC, MPP, and GMLP subsets
isolated from Col1a1-tetO-H2B-mCherry-Fgd5-
ZsGreenmice following H2B-mCherry labeling and
4 weeks chase. Red dashed line indicates the
boundary for ZsGreen positivity.cycle, candidate HSCs might predominantly represent cells that
have permanently lost their key HSC properties (Qiu et al., 2014).
This might be particularly relevant for cell populations that cycle
infrequently and where very few cycling cells can be obtained at
a given moment in time. For such populations, it might be more
feasible, or at least complementary, to study cell function from
the perspective of their proliferative history (Foudi et al., 2009;
Qiu et al., 2014; Wilson et al., 2008).
Recent studies have provided evidence that the contribution
of HSCs to native hematopoiesis might be fundamentally
different from that observed following transplantation (Busch
et al., 2015; Sun et al., 2014). Experimental systems that allow
for evaluation in steady state are therefore crucial to gain a
thorough understanding of normal hematopoiesis. Recent adap-
tations and developments of histone 2B (H2B) fusion protein
labeling systems (Foudi et al., 2009; Qiu et al., 2014; Wilson
et al., 2008) have overcome many of the problems associated
with earlier techniques to probe HSC proliferation in vivo (Chesh-
ier et al., 1999; Kiel et al., 2007; Nygren and Bryder, 2008; Sudo
et al., 2000; Takizawa et al., 2011) and allow for long-term eval-
uation of proliferation dynamics in a truly native setting (Foudi
et al., 2009; Wilson et al., 2008). We therefore here made use
of a doxycycline-inducible H2B-mCherry-labeling system (Egli
et al., 2007) to investigate the proliferative responses of HSPCs
following a range of pressures inflicted on the hematopoietic
system, including transplantation, mobilization, and in vivo
depletion of selected blood cell lineages.2810 Cell Reports 14, 2809–2818, March 29, 2016 ª2016 The AuthorRESULTS
An Inducible H2B-mCherry System to Study Native
Proliferation Dynamics within the Hematopoietic
System
Our aim in this study was to explore the proliferation dynamics of
HSPCs in steady state. For this purpose, we made use of a
transgenic tet-ON mouse model that, upon doxycycline (DOX)
administration, allows for expression of a H2B-mCherry (H2B-
mCherry) fusion protein from the ubiquitously expressed
Col1a1 locus (Col1a1-tetO-H2B-mCherry mice; Figure 1A; Egli
et al., 2007). Following a pulse of H2B-mCherry induction, with
concomitant incorporation of the fluorescent protein into nucle-
osomes, H2B-mCherry is divided between daughter cells upon
proliferation (Figure 1B). As previously shown for H2B-GFP
(Foudi et al., 2009), this permits measurement of H2B-mCherry
fluorescence intensity to be correlated to proliferative history.
We confirmed strong and inducible H2B-mCherry mRNA
expression in homozygous Col1a1-tetO-H2B-mCherry mice af-
ter DOX administration, with minimal promiscuous expression
1 week after DOX withdrawal (Figure 1C).
To clarify to what extent HSPCs in Col1a1-tetO-H2B-mCherry
mice are labeled by H2B-mCherry protein after DOX administra-
tion, we investigated the influence of genetic dose on label
uptake in HSCs by comparing labeling in mice heterozygous or
homozygous for the H2B-mCherry transgene (and rtTA). We
also evaluated the influence of DOX concentration provided tos
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Figure 2. Long-Term but Finite H2B-mCherry Label Retention
in HSCs
(A) Representative FACS histograms of H2B-mCherry label in HSPCs after
indicated chase periods. Grey histograms depict mCherry expression in
HSPCs from non-induced Col1a1-tetO-H2B-mCherry mice. Red histograms
denote H2B-mCherry label in HSPCs pulsed with DOX for 1 week and
analyzed following indicated periods of chase. Numbers indicate the mean %
mCherry-positive cells ± SD over unlabeled controls of the indicated pop-
ulations. (n = 7 at 5 weeks, 12 at 10 weeks, 3 at 18 weeks, 7 at 24 weeks, and 7
at 56 weeks).
(B) Representative histograms depicting H2B-mCherry label in HSPCs iso-
lated from 17-month-old Col1a1-tetO-H2B-mCherry mice, pulsed with DOX
for 1 week, followed by 5 weeks chase (n = 6). Asterisks indicate a significant
difference when comparing the % of mCherry-positive cells over unlabeled
controls in the indicated population isolated from young and old mice.animals. H2B-mCherry label in the HSC compartment was
analyzed by flow cytometry 1 week following DOX administration
(Figure 1D), revealing that HSCs in homozygous animals were
highly and uniformly labeled, with a slightly higher label observed
upon administration of more DOX (2 g/kg versus 200mg/kg). The
beneficial effect of higher DOX concentration on H2B-mCherry
uptake in HSCs was more prominent in heterozygous animals
(Figure 1D). Initial H2B-mCherry label in other primitive progeni-
tor subsets was also analyzed (Figure 1E). Multipotent progeni-Celltors (MPPs) (also called short-term HSCs; LineageSca1+c-
kit+CD48CD150 cells; Kiel et al., 2005, 2008; Pronk et al.,
2007) displayed a uniform initial label, strikingly similar to the
initial label of HSCs, whereas granulocyte/macrophage/
lymphoid progenitors (GMLPs) (LineageSca1+c-kit+CD48+
CD150) and myeloid progenitors (MyP) (LineageSca1c-
kit+CD150) were more heterogeneously labeled. This likely
reflects higher proliferation rates in these compartments
(compared to HSCs and MPPs) during the labeling period, an
interpretation supported by analyses of label dilution after
7 days chase (Figure 1E). Finally, to verify our results using an
alternative approach for cell identification, we generated a dou-
ble reporter strain by crossing H2B-mCherry mice with Fgd5-
ZsGreen mice, which specifically mark the most-primitive
HSPC compartment (Gazit et al., 2014). Following H2B-mCherry
labeling and 4 weeks chase, the highest H2B-mCherry label
retention was observed in HSC and MPP subsets, with highest
Fgd5-ZsGreen expression and concomitant mCherry labeling
observed in HSCs. By contrast, GMLPs were essentially nega-
tive for the Fgd5 reporter and retained less H2B-mCherry label
(Figure 1F). The compatibility of the inducible H2B-mCherry
mice with existing GFP reporter mouse lines illustrates an addi-
tional advantage of this particular model system.
The rapid labeling observed in homozygous animals com-
pared to previously described H2B-labeling strategies (Foudi
et al., 2009; Qiu et al., 2014;Wilson et al., 2008) should be advan-
tageous, as less proliferation-associated label dilution during a
shorter labeling period results in a more-uniform initial H2B-
mCherry label. We therefore decided to use homozygous ani-
mals in combination with high-dose DOX for all subsequent
experiments.
Long-Term H2B-mCherry Label Retention
To analyze steady-state proliferation in HSPCs, cohorts of
Col1a1-tetO-H2B-mCherry mice were administered DOX for
1 week, followed by analysis of label dilution in HSPCs after
different periods of chase (Figure 2A). After 5 weeks chase, the
majority of HSCs andMPPs retained high levels of H2B-mCherry
label. By contrast, most GMLPs andMyPs had retained substan-
tially less H2B-mCherry label. This confirmed a higher prolifera-
tion rate of MyPs in steady state (Nygren and Bryder, 2008), with
GMLPs having an in vivo proliferation rate ‘‘intermediate’’ to that
of HSCs/MPPs and MyPs. After 10 weeks chase, GMLPs and
MyPs had lost all H2B-mCherry label, whereas a large fraction
of MPPs and HSCs retained H2B-mCherry label. Following 18
and 24 weeks of chase, a small fraction of HSCs and MPPs still
retained H2B-mCherry fluorescence, whereas none of the
investigated progenitor subsets displayed any detectable label
retention after 56 weeks of chase. To analyze steady-state pro-
liferation in aged mice, a cohort of 16-month-old Col1a1-tetO-
H2B-mCherry mice was administered DOX for 1 week followed
by 5 weeks of chase (Figure 2B). Whereas no significant differ-
ence in proliferation of HSCs or MPPs could be observed as a
consequence of age, GMLPs from old mice had lost significantly
more H2B-mCherry label compared to GMLPs in young mice.
Collectively, these results confirmed the quiescent nature of
HSCs (Cheshier et al., 1999; Foudi et al., 2009; Wilson et al.,
2008) both in young and aged mice and demonstrated thatReports 14, 2809–2818, March 29, 2016 ª2016 The Authors 2811
Figure 3. The Long-Term Effect of Transplantation on Hematopoi-
etic Stem and Progenitor Cell Proliferation
Two experiments where 33 105 or 13 107 unfractionated bonemarrow (UBM)
cells from Col1a1-tetO-H2B-mCherry mice were transplanted into lethally
irradiated wild-type hosts were performed. After stable reconstitution of the
blood system (16 and 18 weeks after transfer), all recipients were given DOX
for 1 week followed by 4 weeks chase before analysis. Age- and sex-matched
(to the donor cells) non-transplanted control mice were induced and analyzed
simultaneously. Secondary transplantation was performed using 33 106 UBM
cells together with previously transplanted competitor cells. Sixteen weeks
post-secondary transplantation, DOX were given to recipients followed
by 4 weeks chase and H2B-mCherry label retention analysis of donor
HSCs. Displayed are mCherry MFI in HSCs normalized to the mean MFI in
HSCs of controls for each experiment, with error bars denoting themean ±SD.
n = 13 controls, 12 primary recipients receiving 3 3 105 cells, 11 primary re-
cipients of 1 3 107 cells, 4 secondary recipients from primary recipients
receiving 1 3 107 cells, and 14 secondary recipients from primary recipients
transplanted with 3 3 105 cells.
See also Figure S1.MPPs are as quiescent as HSCs in steady state. By contrast, ag-
ing associated with a higher steady-state proliferation rate of
GMLPs.
Transplanted HSCs Maintain Higher Proliferation Rates
Long-Term Post-transplantation
The most commonly used assay to evaluate HSC function is by
transplantation, a regimen that is also in routine clinical practice
for various hematological conditions (Gratwohl et al., 2010). To
investigate how HSC proliferation is affected by transplantation
and whether the transplantation dose might influence these pro-
cesses, we isolated BM cells from unlabeled Col1a1-tetO-H2B-
mCherry mice and transplanted two doses of cells (3 3 105 and
1 3 107 cells) into lethally irradiated mice. As an indicator of he-
matopoietic recovery, we monitored peripheral blood values
over time using automated cell counting. This revealed that white
blood cell counts in all recipients were similar to pre-transplanta-
tion values 16–18 weeks after transplantation (data not shown).
Upon hematopoietic recovery, we induced H2B-mCherry, fol-
lowed by a 4-week chase period. Thereafter, recipients were
sacrificed and H2B-mCherry label in donor HSCs analyzed and2812 Cell Reports 14, 2809–2818, March 29, 2016 ª2016 The Authorcompared to age- and sex-matched non-transplanted control
mice (Figures 3 and S1). Strikingly, the transplanted HSCs from
both cell doses exhibited significant reductions inmCherry levels
compared to the untransplanted controls, demonstrating that
the transplanted HSCs maintained a higher proliferation rate
even 4 months post-transplant. Interestingly, a trend toward
greater H2B-mCherry label dilution was observed in the HSCs
isolated from recipients transplanted with a lower cell dose,
though this did not reach statistical significance. These data
indicate that transplantation of HSCs over a wide cell dose range
greatly influences the long-term proliferation dynamics of HSCs
in the BM.
Serial transplantation is routinely used to evaluate HSC self-
renewal. To assess how such procedures impact HSC turnover
rates, we transplanted BM from a cohort of primary recipients
into secondary recipients, followed by H2B-mCherry labeling
and chase after stable blood cell reconstitution was reached.
Analysis of HSCs from these secondary recipients revealed an
even greater increase in HSC proliferation rates than we had
observed in the primary recipients (Figures 3 and S1). No detect-
able differences in HSC proliferation rates as a consequence of
the initial transplantation dose were observed.
Mobilization Depletes Multipotent Progenitors from the
Bone Marrow and Increases Proliferation of
Hematopoietic Stem and Progenitor Cells
As induced mobilization of HSPCs has been suggested to be in-
terlinked with proliferation (Morrison et al., 1997), we next set out
to investigate this question using the Col1a1-tetO-H2B-mCherry
system. We chose to use a mobilization protocol where an initial
injection of cyclophosphamide (Cy) is combined with multiple in-
jections of granulocyte-colony stimulating factor (G-CSF), which
mimics protocols regularly used to mobilize hematopoietic pro-
genitors in humans before transplantation (Milone et al., 2003).
Previously induced Col1a1-tetO-H2B-mCherry mice were in-
jected with Cy and then once per day for 5 days with G-CSF.
The day after the last G-CSF injection, we analyzed HSPCs in
spleen and BM. As expected, both the frequency and absolute
numbers of the LineageSca1+ckit+ HSPCs were reduced in
the BM of mobilized mice (Figure 4A; data not shown), which
was accompanied by a 6-fold increase in the frequency of these
cells in spleen (Figure 4A). Somewhat surprisingly, mobilizations
caused a selective and almost complete depletion of MPPs from
the BM (Figure 4A). H2B-mCherry label retention in mobilized
mice revealed enhanced proliferation in BMmegakaryocyte pro-
genitors (MkP) and GMLPs. For HSCs, mobilization moderately
increased proliferation in the BM, which was even more pro-
nounced for splenic HSCs (Figure 4B). Finally, comparing H2B-
mCherry label retention in HSPCs from spleen and BM in control
(non-mobilized) mice revealed that splenic HSPCs, and in partic-
ular the more mature GMLP and MkP subsets, had undergone
more proliferation than their BM counterparts in steady state.
The Influence of Acute Depletion of Selected Subsets of
Mature Cells on Hematopoietic Stem and Progenitor
Cell Proliferation
We next decided to evaluate proliferation dynamics of HSPCs
following selected depletion and subsequent recovery of matures
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Figure 4. HSPC Mobilization by Cy and
G-CSF Depletes Multipotent Progenitors
and Induces Proliferation in Bone Marrow
and Splenic HSPCs
Labeled Col1a1-tetO-H2B-mCherry mice were
chased for 4 weeks before Cy/G-CSFmobilization.
One day after the last G-CSF injection, mice were
analyzed and compared to age- and sex-matched
non-mobilized animals.
(A) (Top) FACS plots from BM obtained from con-
trol and mobilized mice, showing depletion of
LSKCD150CD48 (MPP) cells following mobili-
zation. Numbers depict the mean % of Line-
ageSca1+ckit+ (LSK) cells ± SD (blue box) and the
frequency of MPP (green box) and HSC (red box)
subsets of LSK cells. (Bottom) Similar analysis as
in top panels but conducted on spleen cells is
shown.
(B) H2B-mCherry label retention in BM and spleen
from mobilized and control animals were com-
pared in the indicated stem and progenitor
populations. Red and blue histograms depict H2B-
mCherry label in the indicated population from a
representative control and from a mobilized ani-
mal, respectively. Numbers depict % mCherry-
positive ± SD over unlabeled controls. A total of
six control and seven mobilized animals were
analyzed.blood cells, a more defined type of hematopoietic stress. We
administered antibodies in vivo to deplete B cells (Keren et al.,
2011) or Gr1+ myeloid cells (Tepper et al., 1992). Analysis of
peripheral blood cells 3 days after depletion showed a nearly
complete elimination of cells of the respective lineages (Figures
5A and 5C), confirming the efficacy of the depletion strategies.
Next, B cells or Gr1+ cells were depleted from induced Col1a1-
tetO-H2B-mCherry mice followed by H2B-mCherry label reten-
tion analysis. Despite the highly efficient B cell depletion, we
could not observe any changes in proliferation of HSCs, MPPs,
or GMLPs 14 days post-depletion (Figure 5B), suggesting that
more mature progenitors are responsible for the rebound of
the B cell lineage after its acute depletion. Gr1+ depletion slightly
increased proliferation of GMLPs during the first 10 days after
depletion,whereasHSCsandMPPswere unaffected (Figure 5D).
We noted that increased proliferation had occurred in MPPs
5 weeks post-Gr1+ depletion, suggesting that a cellular feed-
back induced by Gr1+ depletion had led to increased prolifera-
tion of a subset of MPPs. However, this did not extend to the
HSC compartment (Figure 5D). These results established that
myeloid cell replenishment recruits more immature progenitors
to proliferate, compared to B cell replenishment, although HSC
proliferation was for the most part unaffected by either type of
depletion.
Proliferation History Reveals Unique Molecular
Characteristics of HSCs
Whereas the initial H2B-mCherry label is uniform in HSCs (Fig-
ure 1D), HSCs retain different levels of label following chase,
which presumably could reflect differences in the molecular
properties of individual HSCs. To investigate this, we decidedCellto study how proliferation history relates to gene expression in
individual HSCs. We therefore next performed indexed fluores-
cence-activated cell sorting (FACS) of HSCs from labeled
Col1a1-tetO-H2B-mCherry mice after 2 or 5 weeks chase
(experimental outline described in Figure 6A), a strategy that
facilitates evaluation of the proliferative history of each index-
sorted HSC. Sorted HSCs were next subjected to gene
expression analysis (Table S1) of a panel of genes including tran-
scription factors, cytokine receptors, surface markers, and cell-
cycle-related genes obtained from previous studies (Moignard
et al., 2013; Qiu et al., 2014; Seita et al., 2012).
To establish how the gene expression patterns obtained
related to proliferative history of individual HSCs, we first per-
formed random forest clustering using expression data from
genes expressed in more than 20% of all candidate HSCs (Fig-
ure 6B). This allowed us to identify four clusters of cells. We
next probed the H2B-mCherry index data from individual
HSCs to the cluster they grouped with, which revealed a clear
difference in the proliferative history between HSCs belonging
to the different clusters (Figure 6C) both after 2 and 5 weeks
chase. Investigating the data further for potential correlations
to other surface markers used to sort HSCs, we could further-
more observe clear and differential expression of both Sca1
and c-kit between the different clusters (Figure 6D, top). HSCs
with a more restricted proliferative history displayed higher
Sca1 expression and lower c-kit expression when compared to
HSCs located in clusters that had proliferated more extensively
(Figure 6D, bottom). Finally, to functionally evaluate the HSC ac-
tivity of cells within the identified clusters, we undertook trans-
plantation experiments of cells prospectively isolated based on
their differential Sca1 and c-kit expression. This revealed thatReports 14, 2809–2818, March 29, 2016 ª2016 The Authors 2813
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Figure 5. The Effects of Mature Cell Deple-
tion on Hematopoietic Stem and Progenitor
Cell Proliferation
(A) FACS plots depicting peripheral blood CD19+
cells before and 3 days after in vivo antibody
mediated depletion of B cells. Numbers depict the
mean % CD19+ cells of all white blood cells ± SD
(n = 3).
(B) Representative FACS histograms of H2B-
mCherry label 2 weeks after B cell depletion.
(C) FACS plots depicting peripheral blood Gr1+
cells before and 3 days after in vivo antibody-
mediated Gr1+ cell depletion. Arrows indicate the
gating hierarchy. Numbers depict the mean % of
cells within the gates ± SD (n = 4).
(D) Representative FACS histograms of H2B-
mCherry label retention 10 days and 5 weeks after
Gr1+ cell depletion (two experiments were per-
formed; n = 8 at 10 days; n = 11 at 5 weeks).Sca1highc-kitlow candidate HSCs (cluster 1) presented with a
more robust reconstitution potential compared to cluster 2 and
3 cells. Reconstitution from cluster 2 and 3 cells also appeared
to decrease rapidly over time (Figure 6E). Strikingly, HSCs
belonging to cluster 4 were almost completely devoid of recon-
stitution potential.
Taken together, these data established that proliferation his-
tory can be an effective marker for further separation of candi-
date HSCs with distinct molecular and functional features and,
as such, illuminates the clear correlation between HSC differen-
tiation and proliferation.
DISCUSSION
With the introduction of transgenic H2B-labeling models in he-
matopoietic research, functional comparisons between HSCs
with differential proliferative histories have revealed that HSCs
that harbor the highest reconstitution capacity after transplanta-
tion are found within the most slowly cycling cells (Foudi et al.,
2009; Wilson et al., 2008). Although convincing, we noted a
lack of several experimental details relating to parameters that
influence on H2B-fusion protein expression but also dilution ki-
netics, as rather limited numbers of mice were analyzed in previ-
ous studies (Foudi et al., 2009).
Using an inducible H2B-mCherry labeling system, we demon-
strate that all HSCs can be highly labeled after only 1 week of in-
duction and that the Tet ON system used here (analogous to the
work of Foudi et al.) is particularly appropriate, given the strict
requirement of DOX for transgene expression. In this regard,
Tet OFF systems should at least in theory be more vulnerable
to experimental artifacts, as they by contrast require continuous
DOX intake during extensive time for continuous repression of
the transgene. The very short labeling period, compared to the
turnover in the HSC compartment, excludes dependence on
proliferation for labeling and reaffirms that H2B labeling to a large
extent is driven by histone exchange (Kimura and Cook, 2001)
that involves the transiently expressed H2B-mCherry. In addition2814 Cell Reports 14, 2809–2818, March 29, 2016 ª2016 The Authorto the obvious benefits of reduced experimental times and costs,
swift labeling is advantageous because proliferation during the
‘‘pulse’’ period can be minimized, thereby inducing a more-
homogeneous initial label. This was clearly illustrated by
comparing the initial label intensity in highly proliferative progen-
itors to the slowly cycling HSCs, which revealed that initial label
is less homogenous in progenitors compared to HSCs due to the
proliferation-associated label dilution during the pulse period.
We did note a minor degree of spontaneous H2B label dilution
during extended chase periods, which might limit very long-
term analysis of deeply quiescent populations and potentially
might obscure resolution between cells that, similarly to HSCs
and MPPs here, differ only slightly in proliferative history. We
find it reasonable that the histone exchange responsible for
H2B-fusion protein incorporation should also influence on label
retention.
In steady state, we observed that HSCs and, perhaps more
surprisingly, MPPs divided slowly compared to other more-
mature hematopoietic progenitors, which was similar regardless
of age. By contrast, the proliferation of GMLPs was increased in
aged animals. According to the standard model of blood forma-
tion, MPPs are progeny of HSCs, but they cannot give rise to
HSCs themselves. Therefore, in a ubiquitous labeling system
such as the one used here, proliferating MPPs identified during
the chase period could be descendants from either HSCs or a
consequence of self-replication. Their label retention is therefore
influenced both by the proliferation rate of HSCs and that of
MPP, whichmight further obscure differences in proliferation be-
tween these closely related cell types. Althoughwe noted a trend
toward less proliferation in HSCs compared to MPPs after
5 weeks chase, this was not as pronounced after longer periods
of chase, likely because considerations of percentage label pos-
itive cells over a control might yield unclear results when there
are only subtle differences in proliferation between populations.
Population homogeneity is another potential factor, which might
explain why the long-term proliferation rates of MPPs and HSCs
are more similar in our experiments than in another report, whichs
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Figure 6. Single-Cell Gene Expression Analysis Combined with Index Sorting of HSCs Identifies Groups of HSCs with Different Proliferation
Histories and Reconstitution Potential
(A) Experimental approach.
(B) Heatmap depicting the gene expression of 80 genes (rows) in 355 single HSCs (columns) from labeled Col1a1-tetO-H2B-mCherry mice after random forest
clustering.
(C) Fluorescence intensity (FI) for mCherry in individual HSCs grouping to the clusters identified in (B). HSCs that were isolated after 2 (left) or 5 (right) weeks chase
are shown in separate diagrams.
(D) (Top) Normalized expression of c-kit and Sca1 in individual HSCs of the identified clusters. (Bottom) In silico plot of Sca1 versus c-kit of candidate HSCs in
clusters 1 and 4 is shown.
(E) One hundred HSCs (CD45.1+), sorted using Sca1 and c-kit gates based on the FACS index data from HSCs in the indicated cluster, were transplanted
competitively into lethally irradiatedWT recipients (CD45.2+). PB was analyzed for myeloid contribution at 4 and 8 weeks after transplantation (n = 6 for recipients
of cluster 1 HSCs, 7 for recipients of cluster 2+3 HSCs, and 7 for recipients of cluster 4 HSCs). Cells in diagrams are grouped and colored according to which
cluster they grouped to. Black lines indicate the median expression for cells in the indicated clusters.
See also Table S1.used a more refined subfractionation of the MPP compartment
(Oguro et al., 2013). Slow proliferation of HSCs and MPPs is
consistent with a recent study (Busch et al., 2015) in which
GMLPs and more mature progenitors were shown to be impor-
tant amplifiers in mature blood cell production, with less
contribution from HSCs. This agrees also with the framework
presented in another recent study of native hematopoiesis
(Sun et al., 2014), in which multipotent (GMLPs) and lineage-
restricted progenitors were proposed to drive hematopoiesis,
with only minor contribution from HSCs. Our studies therefore
consolidate the recent understanding that HSC behavior after
transplantation is fundamentally different from HSC behavior in
more unperturbed settings. More directly, we demonstrate that
the extraordinary pressure put on HSCs after transplantation
alters their proliferative behavior even long-term and upon resto-Cellration of normal hematopoiesis. By contrast, hematopoietic
stress caused by depletion of specific blood lineages (B cells
and granulocytes) exerted little proliferative pressure on HSCs,
with the brunt of such stress being shouldered by more mature
MPPs and/or lineage-restricted progenitors, depending on the
lineage depleted. Myeloid cell depletion induced proliferation
of progenitors immediately downstreamof HSCs, whereas no ef-
fect on proliferation of these immature progenitors was observed
after lymphoid cell depletion. In sharp contrast, systemic mobili-
zation resulted in increases in HSC proliferation, which however
was far less than that observed for downstream progenitors. In
fact, enforced mobilization resulted in a nearly complete deple-
tion of MPPs, highlighting a particularly prominent role of these
cells in emergence hematopoiesis. Our interpretation that
MPPs are transiently depleted following mobilization assumesReports 14, 2809–2818, March 29, 2016 ª2016 The Authors 2815
stable expression of the CD48 marker. Whereas this interpreta-
tion is consistent with stable expression of CD48 and CD150 in
HSPCs throughout ontogeny, acrossmouse strains, and a stable
lack of CD48 in HSCs after transplantation and mobilization (Kiel
et al., 2005; Kim et al., 2006; Yilmaz et al., 2006), we can however
at this point not fully exclude that the stability of CD48 expression
might be different in MPPs.
Following our investigations onHSCproliferation, we set out to
investigate to what extent proliferation history and gene expres-
sion patterns could be utilized to reveal potential heterogeneity
of candidate HSCs. For this, we chose an approach where we
combined indexed single-cell flow cytometric cell sorting and
multiplexed qRT-PCR. This approach allowed successful clus-
tering based on gene expression patterns, which could be corre-
lated to the proliferation history of the candidate HSCs. This
approach also aided us in correlating cell surfacemarker expres-
sion to the gene-expression patterns in individual HSCs. Consis-
tent with previous reports, differential c-kit surface expression
was noted among candidate HSCs (Grinenko et al., 2014; Shin
et al., 2014), with c-kitlow cells displaying a more restricted pro-
liferative history. Reciprocally, and in line with a recent report
(Wilson et al., 2015), we also noted differences in levels of
Sca1 among the separate clusters. Sca1low HSCs had prolifer-
ated substantially more than Sca1high HSCs. Guided by these
observations, prospective isolation in combination with compet-
itive transplantation allowed us to confirm the distinct functional
activities of these subsets (Grinenko et al., 2014; Shin et al.,
2014). Taken together, these data therefore highlight prolifera-
tion history as a marker to further refine populations previously
considered homogenous.
In conclusion, our work adds aspects of HSC proliferation to
other recent studies that have approached steady-state HSC
function (Busch et al., 2015; Sun et al., 2014). Whereas un-
doubtedly essential in the transplantation setting, by which
HSCs have traditionally been functionally evaluated, HSCs
appear to only be a minor contributor to steady-state hemato-
poiesis, and we here reveal that this is directly reflected by their
proliferative history. As a consequence, other more rapidly
proliferating progenitors must have a higher degree of self-
perpetuation than previously appreciated from transplantation
studies, a fact underscored by the extensive cell production
necessary to maintain appropriate homeostasis in the hemato-
poietic system.
EXPERIMENTAL PROCEDURES
Mice
To track proliferation of HSPCs in vivo, Col1a1-tetO-H2B-mCherry mice (Egli
et al., 2007; Jax mice stock number 014602) were used. Except for
experiments with Col1a1-tetO-H2B-mCherry-Fgd5-ZsGreen mice and initial
labeling experiments in which comparison of heterozygous and homozygous
animals were made, homozygous animals were used throughout the study.
Mice were maintained at the animal facilities at BMC at Lund University, and
all animal experiments were performed with consent from a local ethical
committee.
H2B-mCherry Labeling
H2B-mCherry labeling in Col1a1-tetO-H2B-mCherry mice was induced by
administration of high-concentration DOX (2 g/kg; Ssniff Spezialdia¨ten) con-
taining food pellets, except in initial labeling experiments when labeling with2816 Cell Reports 14, 2809–2818, March 29, 2016 ª2016 The Authora lower concentration of DOX (200 mg/kg) was evaluated. For labeling, mice
were fed DOX-containing food pellets for 1 week. Mice with the same geno-
type and gender as experimental animals, but fed with normal food, were
used as negative controls.
qRT-PCR
For evaluation of H2B-mCherry expression in vivo, RNA was extracted from
HSPCs isolated from non-induced Col1a1-tetO-H2B-mCherry mice or from
mice kept for 7 days on Dox-containing (2 g/kg) food pellets followed by no
and 7 days of chase. For qRT-PCR, total RNA was isolated with an RNeasy-
micro mRNA purification kit (QIAGEN) and used for reverse-transcription
with random hexamers using SuperScript III, according to the manufacturer’s
instructions (Invitrogen). Real-time PCR reactions were performed with 1,000
cell equivalents of RNA using a MyiQ single color detection system (Bio-Rad)
using a SYBR Green mix (Invitrogen).
Immunophenotyping and FACS
For HSPC analysis, single-cell suspensions of BM or spleen cells were lineage
depleted using a cocktail of biotinylated antibodies CD11b (M1/70), Gr-1 (RB6-
8C5), Ter119 (Ter119), CD8a (53-6.7), CD4 (GK1.5), B220 (RA3-6B2), with
CD11b excluded from the lineage cocktail in mobilization experiments, and
streptavidin-conjugated magnetic beads (according to manufacturer’s in-
structions, Miltenyi Biotec). Lineage-depleted cells were stained with fluores-
cent-conjugated streptavidin and antibodies. BM cells from mobilized mice
were analyzed without lineage depletion. Erythrocytes were lysed with ammo-
nium chloride before antibody staining. To determine the absolute number of
the indicated cell fractions, overall organ cellularity was assessed using a
Sysmex KX-21 N machine (Sysmex) and correlated with the frequencies of
specific subsets obtained from flow cytometric analyses. HSPC phenotypes
were analyzed as described (Ugale et al., 2014). BM and spleen cells were
sorted and/or analyzed on a FACS Aria III cell sorter (Becton Dickinson). For
blood analysis, peripheral blood was collected from the tail vein and red blood
cells were sedimentedwith 2%Dextran T-500. Remaining red blood cells were
lysed with ammonium chloride before staining with antibodies. Blood was
analyzed on a FACS Aria III cell sorter or an LSRII (Becton Dickinson). Fluores-
cently labeled antibodies were directed against CD19 (1D3), Gr-1 (RB6-8C5),
Sca1 (D7), c-Kit (2B8), CD45.1 (A20), CD45.2 (104), CD41 (MWReg30), CD48
(HM48-1), CD150 (TC15-12F12.2), and CD105 (MJ7/18). The analyzed sub-
sets were distinguished by the following cell surface marker expression:
HSC, LincKit+Sca1+CD48CD150+; MPP, LincKit+Sca1+CD48CD150;
GMLP, LincKit+Sca1+CD48+CD150; MyP, LincKit+Sca1CD150; and
MkP, LincKit+Sca1CD150+CD41+.
Cy/G-CSF Mobilization
Col1a1-tetO-H2B-mCherry mice were H2B-mCherry labeled and chased
for 4 weeks before mobilization. Mice were injected intraperitoneally with
200 mg/kg Cy (Baxter Medical AB) and then for 5 consecutive days
subcutaneously with 250 mg/kg of human G-CSF (Amgen). Control mice
were sham injected with PBS. Mice were analyzed 1 day after the last
injection.
In Vivo Antibody Depletion
B cell depletion was conducted according to a previously described protocol
(Keren et al., 2011) by intraperitoneally injecting 150 mg/mouse rat anti-mouse
CD19 and CD22 (clones 1D3 and CY34.1; Bio X Cell) and rat anti-mouse B220
(clone: RA3-6B2; eBioscience). Forty-eight hours later, 150 mg/mouse of anti-
rat kappa light chain (clone: MAR18.5; Bio X Cell) was injected intraperitone-
ally. Neutrophil depletion was achieved by injecting 500 mg of anti-mouse
Ly-6G (clone: RB6-8C5; Bio X Cell) intraperitoneally into mice on days 0 and
5. Analysis was performed on the indicated days after the last injection. In all
antibody depletion experiments, DOX pellets were removed when the first
injections were made.
Transplantation Experiments
33 105 or 13 107 unfractionated BM cells from uninduced Col1a1-tetO-H2B-
mCherry mice were transplanted into lethally irradiated (800–950 rad) C57Bl/6
CD45.1mice. For secondary transplantations, 33 106 unfractionated BM cellss
from primary recipients were transplanted into lethally irradiated C57Bl/6
CD45.1 recipients or F1 C57Bl/6 CD45.1 3 C57Bl/6 CD45.2 mice, together
with 3 3 106 previously transplanted C57bl/6 CD45.1 competitor cells (Rund-
berg Nilsson et al., 2015). When total white blood cell values had reached
normal levels in primary or secondary transplanted recipient mice (16 or
18 weeks after transplantation), H2B-mCherry was induced and followed by
4 weeks chase before assessing HSPC proliferation.
Multiplex qRT-PCR Analysis Using the Fluidigm Biomark HD
Platform
Individual HSCs isolated from 2 or 5weeks chasedCol1a1-tetO-H2B-mCherry
mice were index sorted, using a LinSca1+c-kit+CD48CD150+ phenotype,
into individual wells of a 96-well PCR plate containing 5 ml lysis buffer
(10 mM TrisHCl [pH 8.0], 0,1 mM EDTA, 0.1 units/ml SUPERase-In [Life
Technologies], and 0.5% NP40 [Sigma]). Plates with sorted cells were snap
frozen on dry ice and stored at 80C until further processing. For cDNA
synthesis, qScript cDNA supermix (Quanta Bioscience) was used. Specific
target amplification (STA) of genes of interest were performed in multiplex
using 96 Delta Gene assays and TATAA preAmp GrandMaster Mix (Tataa Bio-
center) using cycling conditions of 95C for 10 min followed by 223 (96C for
15 s; 60C for 6min). After STA, samples were treated with Exonuclease I (New
England Biolabs) at 37C for 30 min to remove excess primers. Thereafter,
inactivation of the enzyme was performed at 80C for 15 min. The cDNA
was diluted five times with TE low buffer (10 mM TrisHCl [pH 8.0] and
0.1 mM EDTA) prior to qPCR on the BioMark HD (Fluidigm). All primers were
used at 500 nM in the final reaction, and EvaGreen Supermix with Low ROX
(Bio-Rad) was used for detection of the qPCR products. The qPCR was per-
formed using the 96.96 Dynamic Array Integrated Fluidic Circuits (IFC) (Fluid-
igm) chip in combination with the BioMark HDwith the following thermal cycler
program: thermal mix 70C for 4 min followed by 60C for 30 s, hot start 95C
for 60 s, and PCR cycle 303 (96C5 s; 60C for 20 s), followed bymelting curve
analysis.
Random forest clustering was performed using R functions located at
https://labs.genetics.ucla.edu/horvath/RFclustering/RFclustering.htm, which
at its core uses the ‘‘randomForest’’ package, which is hosted at the offi-
cial R repository at https://cran.r-project.org/web/packages/randomForest/
index.html. Using these functions, as documented without modification, will
perform random forest clustering as described in the manuscript. The param-
eters we used in the random forest dist function were mtry1 = 3 no.tree = 433
and no.rep = 224. Before random forest clustering (Shi and Horvath, 2006),
data from failed assays and non-expressed genes (expressed in <20% of
the cells; 14 genes) were excluded. Data from no template controls and
from failed cells were also removed. Random forest clustering is a process
by which decision trees are generated and used to define the distance be-
tween variables (in this case cells). Random forest clustering is an adaptation
of its use as a classification tool that has been used extensively to analyze bio-
logical data due to its accuracy and speed. Random forest clustering offers
several advantages over other clustering methods such as hierarchical and
k-means for the following reasons: first, random forest clustering is rank
based, which means transformations made to the data have no effect on the
outcome, as long as the ranks are preserved. Second, random forest clus-
tering does not rely on user-specified thresholds. There is no need to supply
linkagemethods, the number of partitions expected, and cutoffs to define sim-
ilarity. This means random forest clustering is truly unsupervised and removes
user bias. Third, random forests are more resistant to outliers and weight each
variable individually, leading to increased sensitivity. Random forest clustering
was performed multiple times on the dataset with very similar results. The
heatmap in Figure 6B was prepared using Single Cell expression Visualizer
(Lang et al., 2015; http://stemsysbio.bmc.lu.se/SCexV). Significance values
were calculated by using Tukey’s multiple comparisons test in Graphpad
Prism or with Student’s two-tailed t test (Figure 2B) in Microsoft Excel
(*p < 0.05; **p < 0.01; ***p < 0.001).
Statistical Analysis
Data were analyzed using Microsoft Excel (Microsoft) and Graphpad Prism
(GraphPad Software). All FACS analyses were performed using Flowjo soft-
ware (TreeStar).CellACCESSION NUMBERS
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